Table 2.
AS2 for gene expression in P. aeruginosa PAO1
Model | AS2, % | ||
Combined in vivo | Sputum | Chronic wound/burn | |
Resampled in vivo | 100 | 100 | 100 |
Mouse wound model | 92 | 84 | 88 |
SCFM2 | 91 | 82 | 88 |
CFECs | 86 | 79 | 82 |
RPMI | 85 | 74 | 82 |
RPMI/serum | 84 | 72 | 81 |
RSV-CFECs | 83 | 75 | 81 |
Mops succinate | 80 | 72 | 76 |
LB | 77 | 69 | 76 |
MHB | 72 | 65 | 70 |
AS2 for gene expression in P. aeruginosa PAO1 grown in MHB, RPMI + 5% MHB (RPMI), and RPMI + 5% MHB + 20% human serum (RPMI/serum) and previously published in vitro models, when compared to in vivo transcriptomes in CF sputum and chronic wound (31), showed greater similarity between the host-mimicking conditions used in this study and in vivo samples cf. nutrient-rich laboratory media. The percentage of genes within 2 SDs (AS2) of the mean expression for each gene in CF sputum (total, 2,437 genes) and chronic wound samples (957 genes) or a combined in vivo dataset (835 genes) (31) was determined with z-score calculations using the mean of normalized read counts.